no image available Dickens & Co. "Beating the Odds: Trastuzumab's Lasting Impact on HER2-Positive Breast Cancer" "New Insights from the HEROS Patient Registry Uncover Durable Remission in Metastatic Breast Cancer Patients" Price: 22.00€